A selection of recent presentations and posters presented by the London Sarcoma Service team can be found below:

  • International CTOS 2023 (Presentation) WHAT ARE THE EXPERIENCES OF GAIT, ACTIVITY LEVELS AND PHYSICAL FUNCTIONING IN PROXIMAL FEMORAL REPLACEMENT AFTER MUSCULOSKELETAL TUMORS?
  • International CTOS 2023 (Presentation) REAL-WORLD MONITORING OF PHYSICAL ACTIVITY USING AN ACCELEROMETER AFTER LOWER LIMB SURGERY FOR A SARCOMA.
  • International CTOS 2023 (Presentation) EXPERIENCE OF PHYSICAL DISABILITIES AND CANCER-RELATED QUALITY OF LIFE AFTER SPINAL TUMORS- STUDY OF A NATIONAL SURVEY IN ENGLAND.
  • International CTOS 2023 (Presentation) BALANCE, GAIT AND BIOMECHANICAL COMPENSATIONS DURING DIFFERENT SPEEDS OF WALKING AFTER TREATMENT FOR DISTAL FEMORAL MUSCULOSKELETAL TUMOURS AND ASSOCIATED LIMITATIONS ON RETURN TO NORMAL LIVING
  • International CTOS 2023 (Presentation) WHAT IS THE EXPERIENCE OF THOSE WITH CANCER-RELATED REDUCED QUALITY OF LIFE AND ASSOCIATED PHYSICAL DISABILITIES AFTER UPPER LIMB SARCOMA TREATMENT IN ENGLAND? A NATIONAL STUDY OF OUTCOMES.
  • International CTOS 2023 (Presentation) WHAT ARE THE EXPERIENCES OF BALANCE, GAIT AND NEURO-MUSCULAR CONTROL OUTCOMES AFTER PROXIMAL FEMORAL REPLACEMENTS FOR MUSCULOSKELETAL TUMOURS?
  • International CTOS 2023 (Presentation) UNDERSTANDING THE EXPERIENCES OF PATIENTS RETURNING TO ACTIVITIES OF DAILY LIVING AND EXERCISE FOLLOWING LIMB SPARING SURGERY FOR BONE OR SOFT TISSUE SARCOMA AROUND THE KNEE.
  • International CTOS 2023 (Presentation) GAIT KINEMATICS OF SARCOMA PATIENTS AT 1 YEAR POST-OPERATIVE INTERNAL HEMIPELVECTOMY SURGERY: A RETROSPECTIVE STUDY
  • International CTOS 2023 (Presentation) BALANCE AND GAIT OUTCOMES AFTER 1-YEAR POST-OPERATIVE HEMIPELVECTOMY SURGERY
  • International CTOS 2023 (Poster) THE EVALUATION AND OUTCOMES OF MESENTERIC AND INTRA-ABDOMINAL DESMOIDS: A TARPSWG STUDY
  • International CTOS 2023 (Poster) Dosimetric Characteristics, Outcomes and Prognostic Factors of patients with Extracranial chordomas and chondrosarcomas treated with High Dose Radiotherapy: A Large Single Institution Cohort
  • International CTOS 2023 (Presentation)-  THE CELL ATLAS OF CLEAR CELL SARCOMA
  • International CTOS 2023 (Presentation) - THE GENOMIC LANDSCAPE OF CLEAR CELL SARCOMA
  • International CTOS 2023 (Poster) - EPIGENETIC AGE ACCELERATION IS A DISTINCTIVE TRAIT OF EPITHELIOID SARCOMA WITH POTENTIAL THERAPEUTIC IMPLICATIONS
  • International CTOS 2023 (Poster) - Dimosthenis A, et al Controversies in the management of patients with soft tissue sarcoma: results and recommendations from the first Conference on State of Science in Sarcoma (CSSS) Connective Tissue Oncology Society, 2023 Annual Meeting Poster.

  • International CTOS 2023 (Poster) - Wild T et al. The evaluation and outcomes of mesenteric and intra-abdominal desmoids: a TARPSWG Study. Connective Tissue Oncology Society, 2023 Annual Meeting Poster.

  • International CTOS 2023 (Poster) - Palmerini E et al. Ultra-rare Undifferentiated Small Round Cell Sarcoma: how should we treat them? An analysis from the GRACEFUL project. Connective Tissue Oncology Society, 2023 Annual Meeting Poster.

  • International EMSOS 2021 (Podium) - Can Holistic personalised models of rehabilitation improve survivorship outcomes after treatment for lower extremity sarcoma? – A Preliminary Efficacy Study - Selected for EMSOS 2021
  • International EMSOS 2021 (Podium) - Prevalence and Risk Factors for Falls in Patients Treated for Lower Extremity Sarcoma – Selected for European Musculoskeletal Oncology Society (EMSOS) 2021 conference
  • National BSG 2021 (Podium) Embedding Personalised Cancer Care into the Sarcoma Patient Pathway

  • National BSG 2021 (Poster) - Physical function following bone reconstruction versus no bone reconstruction for pelvic primary bone sarcoma – a systematic review - Presented at British Sarcoma Group (BSG) 2021

  • National BSG 2021 (Poster) - What Do We Know about the Lived experience of Pain and Fatigue after Treatment for Extremity Sarcoma? - A Systematic Review – Presented at BSG 2021
  • National BSG 2021 (Poster) - Expectations of mobility following lower limb massive endo-prosthetic replacement (EPR) for primary bone sarcoma in children – Presented at BSG 2021
  • National BSG 2021 (Podium) - Walking Balance and Compensatory Gait Mechanisms in Surgically treated Patients for Pelvic Musculoskeletal tumours – A Presentation of Preliminary Findings - Presented at BSG 2021
  • International EMSOS 2021 (Podium) - Feasibility of using the Patient Specific Functional Score to guide Inpatient Rehabilitation after Surgery for Musculoskeletal tumours – Selected for EMSOS 2021
  • International EMSOS 2021 (Podium) - Service Evaluation of Adult Orthopaedic Oncology Inpatient Rehabilitation Programme - Selected for EMSOS 2021
  • International EMSOS 2021 (Podium) - Service Evaluation of Therapy Management after Proximal Femoral Replacement for Metastatic Bone Disease – A Retrospective Analysis of 10 cases – Selected for EMSOS 2021
  • National BSG 2022 (Poster) - Personalised Cancer Care. Introducing Holistic Needs Assessment into a Sarcoma Service - Patient and Clinician Experience
  • National BSG 2022 (Poster) - What is the Burden of Long-term Physical Limitations after Surgery for Extremity Sarcoma?
  • National BSG 2022 (Poster) - Developing Rehabilitation Guidelines following Proximal Femoral Replacement Surgery
  • National BSG 2022 (Poster) - Identifying barriers in the Paediatric Bone Sarcoma Rehabilitation pathway in South East England
  • National BSG 2022 (Poster) - Stanmore Children's Orthopaedic Outcome Project (SCOOP): Preliminary Findings of Children and Young Adults' Experience after Orthopaedic Surgery
  • National BSG 2022 (Poster) - The Role of Post-operative Radiotherapy in Osteosarcoma: A Retrospective Analysis from the London Sarcoma Service (LSS)
  • National BSG 2022 (Poster) - Role of adjuvant pelvic radiotherapy in localised leiomyosarcomas and undifferentiated endometrial sarcomas
  • National BSG 2022 (Presentation) - A review of psychosocial needs of patients in the Sarcoma Patient Pathway using the electronic Holistic Needs Assessment (eHNA)